CNBC recognizes Moderna as one of the top 10 companies whose innovations are having a dramatic impact across their industries.learn more

Alexion and Moderna have an exclusive strategic agreement for the discovery and development of messenger RNA Therapeutics™ for rare diseases.

learn more

Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.

learn more

Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.

learn more

We are delivering the next wave of innovation to treat serious illness.

here's how

We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.

get to know us

1
2
3
4
5
6

What's New

October 16, 2014

Moderna to Collaborate with Karolinska Institutet and Karolinska University | Read more

July 1, 2014

Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido | Read more

June 17, 2014

Moderna Named to CNBC Disruptor 50 List | Read more